Gene set enrichment analysis (GSEA) showed that IGF2BP2 led to a poor prognosis in OSCC by affecting cancer-related (epithelial-mesenchymal transition, glycolysis, cell cycle, etc.)and immune-related biological functions and pathways. This evidence concerns the gene IGF2BP2 and cancer.